JKJürgen Knobloch

Jürgen Knobloch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jürgen Knobloch has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Ingo Schmitz

    Department of Molecular Immunology, Ruhr University Bochum, Bochum, Germany

    1 shared publication
  • Katrin Götz

    Institute for Animal Developmental and Molecular Biology,1 Institute of Molecular Medicine, Heinrich Heine University, D-40225 Düsseldorf, Germany2

    1 shared publication
  • Klaus Schulze-Osthoff

    Institute for Animal Developmental and Molecular Biology,1 Institute of Molecular Medicine, Heinrich Heine University, D-40225 Düsseldorf, Germany2

    1 shared publication
  • Ulrich Rüther

    Institute for Animal Developmental and Molecular Biology,1 Institute of Molecular Medicine, Heinrich Heine University, D-40225 Düsseldorf, Germany2

    1 shared publication

Latest Publications

  • Open Access

    Thalidomide Induces Limb Anomalies by PTEN Stabilization, Akt Suppression, and Stimulation of Caspase-Dependent Cell Death

    by Jürgen Knobloch, Ingo Schmitz, Katrin Götz, Klaus Schulze-Osthoff, Ulrich Rüther

    Thalidomide, a drug used for the treatment of multiple myeloma and inflammatory diseases, is also a teratogen that causes birth defects, such as limb truncations and microphthalmia, in humans. Thalidomide-induced limb truncations result from increased cell death during embryonic limb development and consequential disturbance of limb outgrowth. Here we demonstrate in primary human embryonic cells and in the chicken embryo that thalidomide-induced signaling through bone morphogenetic proteins (Bmps) protects active PTEN from proteasomal degradation, resulting in suppression of Akt signaling. As a consequence, caspase-dependent cell death is stimulated by the intrinsic and Fas death receptor apoptotic pathway. Most importantly, thalidomide-induced limb deformities and microphthalmia in chicken embryos could be rescued by a pharmacological PTEN inhibitor as well as by insulin, a stimulant of Akt signaling. We therefore conclude that perturbation of PTEN/Akt signaling and stimulation of caspase activity is central to the teratogenic effects of thalidomide.